134 related articles for article (PubMed ID: 36825353)
21. Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis.
Corpechot C; Chazouillères O; Belnou P; Montano-Loza AJ; Mason A; Ebadi M; Eurich D; Chopra S; Jacob D; Schramm C; Sterneck M; Bruns T; Reuken P; Rauchfuss F; Roccarina D; Thorburn D; Gerussi A; Trivedi P; Hirschfield G; McDowell P; Nevens F; Boillot O; Bosch A; Giostra E; Conti F; Poupon R; Parés A; Reig A; Donato MF; Malinverno F; Floreani A; Russo FP; Cazzagon N; Verhelst X; Goet J; Harms M; van Buuren H; Hansen B; Carrat F; Dumortier J;
J Hepatol; 2020 Sep; 73(3):559-565. PubMed ID: 32275981
[TBL] [Abstract][Full Text] [Related]
22. Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: The SURFASA score.
De Martin E; Coilly A; Chazouillères O; Roux O; Peron JM; Houssel-Debry P; Artru F; Silvain C; Ollivier-Hourmand I; Duvoux C; Heurgue A; Barge S; Ganne-Carrié N; Pageaux GP; Besch C; Bourlière M; Fontaine H; de Ledinghen V; Dumortier J; Conti F; Radenne S; Debette-Gratien M; Goria O; Durand F; Potier P; Di Martino V; Reboux N; Ichai P; Sebagh M; Mathurin P; Agostini H; Samuel D; Duclos-Vallée JC;
J Hepatol; 2021 Jun; 74(6):1325-1334. PubMed ID: 33503489
[TBL] [Abstract][Full Text] [Related]
23. Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients.
Molmenti EP; Netto GJ; Murray NG; Smith DM; Molmenti H; Crippin JS; Hoover TC; Jung G; Marubashi S; Sanchez EQ; Gogel B; Levy MF; Goldstein RM; Fasola CG; Gonwa TA; Klintmalm GB
Liver Transpl; 2002 Jun; 8(6):519-26. PubMed ID: 12037782
[TBL] [Abstract][Full Text] [Related]
24. A case study: refractory recurrent autoimmune hepatitis following liver transplantation in two male patients.
Tencate V; Komorowski R; Cronin D; Hong J; Gawrieh S
Transplant Proc; 2014; 46(1):298-300. PubMed ID: 24507072
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune hepatitis and liver transplantation: indications, results, and management of recurrent disease.
Tripathi D; Neuberger J
Semin Liver Dis; 2009 Aug; 29(3):286-96. PubMed ID: 19676001
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of a prognostic score for long-term transplant-free survival in autoimmune hepatitis type 1.
Biewenga M; Verhelst XPDMJ; Baven-Pronk MAMC; Putter H; van den Berg AP; van Nieuwkerk KCMJ; van Buuren HR; Bouma G; de Boer YS; Simoen C; Colle I; Schouten J; Sermon F; van Steenkiste C; van Vlierberghe H; van der Meer AJ; Nevens F; van Hoek B;
United European Gastroenterol J; 2021 Jul; 9(6):662-671. PubMed ID: 34165262
[TBL] [Abstract][Full Text] [Related]
27. Early Predictors of Long-term Outcomes of HCV-negative Liver Transplant Recipients Having Survived the First Postoperative Year.
Åberg F; Nordin A; Toivonen L; Isoniemi H
Transplantation; 2016 Feb; 100(2):382-90. PubMed ID: 26683515
[TBL] [Abstract][Full Text] [Related]
28. Increased risk of portal vein thrombosis in patients with autoimmune hepatitis on the liver transplantation waiting list.
Ruiz P; Sastre L; Crespo G; Blasi A; Colmenero J; García-Valdecasas JC; Navasa M
Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28489255
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune hepatitis as a late complication of liver transplantation.
Hernandez HM; Kovarik P; Whitington PF; Alonso EM
J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):131-6. PubMed ID: 11321380
[TBL] [Abstract][Full Text] [Related]
30. Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis.
Venick RS; McDiarmid SV; Farmer DG; Gornbein J; Martin MG; Vargas JH; Ament ME; Busuttil RW
Am J Transplant; 2007 Apr; 7(4):955-63. PubMed ID: 17391135
[TBL] [Abstract][Full Text] [Related]
31. Long Term Outcomes of Liver Transplantation For Patients With Autoimmune Hepatitis.
Alswat K; Soliman E; Salih I; Bashmail A; Letierce A; Benmousa A; Alghamdi S; Bzeizi KI; Alqahtani SA; Shawkat M; Broering DC; Al-Hamoudi WK
Transplant Proc; 2021 Sep; 53(7):2339-2345. PubMed ID: 34474912
[TBL] [Abstract][Full Text] [Related]
32. Possible benefit of splenectomy in liver transplantation for autoimmune hepatitis.
Xu YT; Liu DJ; Meng FY; Li GB; Liu J
Hepatobiliary Pancreat Dis Int; 2014 Jun; 13(3):328-31. PubMed ID: 24919618
[TBL] [Abstract][Full Text] [Related]
33. Comparative Analysis of the Clinical Outcomes of Liver Transplantation for Probable and Definite Auto-immune Hepatitis by International Diagnostic Scoring Criteria.
Cho CW; Kwon CHD; Kim JM; Choi GS; Joh JW; Lee SK
Transplant Proc; 2017 Jun; 49(5):1126-1128. PubMed ID: 28583541
[TBL] [Abstract][Full Text] [Related]
34. Recurrence of autoimmune liver disease and inflammatory bowel disease after pediatric liver transplantation.
Liberal R; Vergani D; Mieli-Vergani G
Liver Transpl; 2016 Sep; 22(9):1275-83. PubMed ID: 27257963
[TBL] [Abstract][Full Text] [Related]
35. Liver transplantation for autoimmune hepatitis.
Reich DJ; Fiel I; Guarrera JV; Emre S; Guy SR; Schwartz ME; Miller CM; Sheiner PA
Hepatology; 2000 Oct; 32(4 Pt 1):693-700. PubMed ID: 11003612
[TBL] [Abstract][Full Text] [Related]
36. Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation.
Miyagawa-Hayashino A; Haga H; Egawa H; Hayashino Y; Sakurai T; Minamiguchi S; Tanaka K; Manabe T
Transplantation; 2004 Jul; 78(1):128-35. PubMed ID: 15257051
[TBL] [Abstract][Full Text] [Related]
37. The impact of disease recurrence on graft survival following liver transplantation: a single centre experience.
Rowe IA; Webb K; Gunson BK; Mehta N; Haque S; Neuberger J
Transpl Int; 2008 May; 21(5):459-65. PubMed ID: 18225996
[TBL] [Abstract][Full Text] [Related]
38. The clinical characteristics, pre- and post-liver transplantation outcomes in patients having autoimmune overlap syndromes.
Chayanupatkul M; Fiel MI; Schiano TD
Clin Transplant; 2020 May; 34(5):e13841. PubMed ID: 32073690
[TBL] [Abstract][Full Text] [Related]
39. Potential benefit of mixed lymphocyte reaction assay-based immune monitoring after living donor liver transplantation for recipients with autoimmune hepatitis.
Sakai H; Ishiyama K; Tanaka Y; Ide K; Ohira M; Tahara H; Abe T; Hirata F; Morimoto H; Hashimoto S; Tanimine N; Saeki Y; Shimizu S; Yano T; Kobayashi T; Tashiro H; Ohdan H
Transplant Proc; 2014 Apr; 46(3):785-9. PubMed ID: 24767349
[TBL] [Abstract][Full Text] [Related]
40. Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation.
Visseren T; Darwish Murad S
Best Pract Res Clin Gastroenterol; 2017 Apr; 31(2):187-198. PubMed ID: 28624107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
